Breaking News

BioDuro Opens Shanghai Lab

May 15, 2013

Expands discovery services in Asia Pacific

BioDuro, a PPD Company, has opened a new lab in Shanghai, expanding its drug discovery services in Asia Pacific. The new lab is located in the Waigaoqiao Free Trade Zone, close to local and multinational pharmaceutical and biotechnology companies in Shanghai.
 
The 72,000-sq.-ft. lab, along with 20,000 sq. ft. of office space, offers drug metabolism and pharmacokinetic (DMPK), bioanalytical, chemistry, discovery biology and oncology pharmacology services. Clients also are able to take advantage of PPD’s clinical research services, as well as its library of assays.
 
“As a fully integrated life science research service provider, BioDuro has an experienced team of researchers and scientists with expertise in a wide range of drug discovery services,” said Jasmine Cui, Ph.D., general manager and chief scientific officer of BioDuro. “This new lab will allow us to meet the business needs of our clients more effectively by streamlining the discovery and development process, and continuing to enhance continuity and smooth transitions throughout the stages of development.”

blog comments powered by Disqus
  • CMC Biologics: Growing Through Innovation

    Tim Wright, Editor||January 28, 2016
    The new chief exec talks about industry trends and growth plans.

  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • A Look at DCAT Week ‘16

    Tim Wright, Editor||January 28, 2016
    On the pulse of the pharmaceutical manufacturing value chain, DCAT Week ‘16 will deliver top-flight education programs and networking events.